| Devora G Swertloff, MA, CF-SLP | |
|
2 Stacy Ct, Jackson, NJ 08527-2912 | |
| (732) 664-8874 | |
| Not Available |
| Full Name | Devora G Swertloff |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2 Stacy Ct, Jackson, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134775430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Devora G Swertloff, MA, CF-SLP 64 Laurel Ave, Clifton, NJ 07012-1217 Ph: (973) 830-6709 | Devora G Swertloff, MA, CF-SLP 2 Stacy Ct, Jackson, NJ 08527-2912 Ph: (732) 664-8874 |
News Archive
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.
Saladax Biomedical, Inc. announced today that it has entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb Company for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
WHO and the International Olympic Committee are teaming up to promote healthy lifestyle choices, including physical activity, sports for all, Tobacco Free Olympic Games, and the prevention of childhood obesity. As outlined in a memorandum of understanding signed today in Lausanne, the WHO and IOC will work at both the international and country level to promote activities and policy choices to help people reduce their risk of noncommunicable diseases such as cardiovascular disease, cancers, and diabetes.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
› Verified 6 days ago
Mrs. Tyler Toland, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Mills Ln, Jackson, NJ 08527 Phone: 732-245-7805 | |
Mrs. Andrea S Cooper, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 Portchester Dr, Jackson, NJ 08527 Phone: 732-580-8624 | |
Chaya B. Pekier, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Stacy Ct, Jackson, NJ 08527 Phone: 414-719-8135 | |
Shoshana Robinson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Stacy Ct, Jackson, NJ 08527 Phone: 732-664-8874 | |
Cheryl Mozes, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33 Rutgers Rd, Jackson, NJ 08527 Phone: 845-521-2913 Fax: 845-521-2913 | |
Mindy Segal, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Stacy Ct, Jackson, NJ 08527 Phone: 732-664-8874 |